Novartis launches new Entresto trials in bid to boost sales

ZURICH, May 19 (Reuters) - Novartis's heart failure

drug Entresto will be subjected to a battery of new trials as

the Swiss drugmaker seeks to boost the medicine after a

disappointing introduction.

Read more